Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotero Revive PMCF study in facial skin revitalization and photo-damaged skin
DRKS00025699Phase 4Completed
- Sponsor
- Merz
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Belotero Revive in photoaging (2 arms), sponsored by Merz. Started Jul 2021; status: completed.
02
Drugs
Belotero Revive
03
Conditions
photoaging
Beyond the preview
Go deeper on DRKS00025699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025699.